Total Payments
$10,839
2024 Payments
$1,753
Companies
31
Transactions
633
Medicare Patients
3,751
Medicare Billing
$674,516
Payment Breakdown by Category
Food & Beverage$10,332 (95.3%)
Other$300.00 (2.8%)
Education$206.93 (1.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,332 | 621 | 95.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $300.00 | 1 | 2.8% |
| Education | $206.93 | 11 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,714 | 107 | $0 (2024) |
| Lilly USA, LLC | $1,561 | 78 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,127 | 55 | $0 (2024) |
| Antares Pharma, Inc. | $850.73 | 49 | $0 (2024) |
| Novo Nordisk Inc | $818.88 | 64 | $0 (2023) |
| Radius Health, Inc. | $744.78 | 39 | $0 (2024) |
| ABBVIE INC. | $728.62 | 44 | $0 (2024) |
| Tandem Diabetes Care, Inc. | $353.28 | 4 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $351.49 | 26 | $0 (2019) |
| Supernus Pharmaceuticals, Inc. | $287.43 | 14 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,753 | 98 | Lilly USA, LLC ($525.38) |
| 2023 | $1,603 | 77 | AstraZeneca Pharmaceuticals LP ($300.76) |
| 2022 | $1,767 | 105 | AstraZeneca Pharmaceuticals LP ($325.62) |
| 2021 | $1,564 | 86 | Lilly USA, LLC ($282.12) |
| 2020 | $1,423 | 71 | Amgen Inc. ($584.07) |
| 2019 | $1,008 | 52 | Tandem Diabetes Care, Inc. ($300.00) |
| 2018 | $602.69 | 48 | AbbVie, Inc. ($157.66) |
| 2017 | $1,119 | 96 | Janssen Pharmaceuticals, Inc ($288.37) |
All Payment Transactions
633 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $28.87 | General |
| Category: Bone Health | ||||||
| 12/09/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 12/02/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/02/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $7.10 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/21/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $26.87 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Bone Health | ||||||
| 11/12/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/12/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $5.30 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/05/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 11/01/2024 | Lilly USA, LLC | JARDIANCE (Drug), LYUMJEV | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $29.89 | General |
| Category: Bone Health | ||||||
| 10/24/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $6.66 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/22/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $5.30 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/21/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 10/17/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Endocrinology | ||||||
| 10/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $30.40 | General |
| Category: Diabetes | ||||||
| 10/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/04/2024 | Lilly USA, LLC | JARDIANCE (Drug), LYUMJEV | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Endocrinology | ||||||
| 10/01/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/01/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $8.11 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/24/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 1,096 | 5,081 | $677,921 | $224,833 |
| 2022 | 7 | 1,045 | 3,777 | $629,471 | $206,698 |
| 2021 | 5 | 811 | 1,192 | $372,000 | $138,263 |
| 2020 | 5 | 799 | 1,145 | $348,630 | $104,722 |
Total Patients
3,751
Total Services
11,195
Medicare Billing
$674,516
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 609 | 897 | $358,800 | $95,781 | 26.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 52 | 3,600 | $81,036 | $61,319 | 75.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 198 | 321 | $128,400 | $48,103 | 37.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 104 | 115 | $46,000 | $8,373 | 18.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 59 | 59 | $47,200 | $7,288 | 15.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $14,000 | $3,189 | 22.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 56 | 71 | $2,485 | $779.98 | 31.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 520 | 712 | $274,800 | $74,488 | 27.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 237 | 450 | $173,400 | $67,200 | 38.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 40 | 2,341 | $52,696 | $39,237 | 74.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 57 | 57 | $43,200 | $9,602 | 22.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 63 | 63 | $48,600 | $8,844 | 18.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 81 | 89 | $34,500 | $6,514 | 18.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 47 | 65 | $2,275 | $812.95 | 35.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 479 | 691 | $207,300 | $71,511 | 34.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 197 | 358 | $107,400 | $52,255 | 48.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 87 | 95 | $28,500 | $6,833 | 24.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 31 | 31 | $18,600 | $4,488 | 24.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 17 | 17 | $10,200 | $3,175 | 31.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 456 | 621 | $186,300 | $50,778 | 27.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 220 | 393 | $117,900 | $45,117 | 38.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 79 | 80 | $24,000 | $4,447 | 18.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 33 | 33 | $19,800 | $4,275 | 21.6% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 11 | 18 | $630.00 | $104.79 | 16.6% |
About Dr. Eric Buxton, M.D
Dr. Eric Buxton, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134210362.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Buxton, M.D has received a total of $10,839 in payments from pharmaceutical and medical device companies, with $1,753 received in 2024. These payments were reported across 633 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($10,332).
As a Medicare-enrolled provider, Buxton has provided services to 3,751 Medicare beneficiaries, totaling 11,195 services with total Medicare billing of $674,516. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location San Francisco, CA
- Active Since 09/26/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1134210362
Products in Payments
- EVENITY (Biological) $1,155
- FARXIGA (Drug) $1,034
- XYOSTED (Drug) $808.28
- JARDIANCE (Drug) $585.93
- Tymlos (Biological) $522.20
- TRULICITY (Drug) $465.54
- MOUNJARO (Drug) $416.75
- SYNTHROID (Drug) $415.16
- INVOKANA (Drug) $345.47
- Prolia (Biological) $340.82
- NOCDURNA (Drug) $303.53
- t-slim insulin pump (Device) $300.00
- Gonal-f (Biological) $264.10
- Saxenda (Drug) $251.06
- Tirosint (Drug) $235.64
- Omnipod (Device) $234.66
- Synthroid (Drug) $228.52
- AFREZZA (Drug) $213.68
- Tymlos (Drug) $208.06
- STRENSIQ (Biological) $194.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in San Francisco
Cheng-Yang Tuan, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $672,998
Endocrinology, Diabetes & Metabolism $672,998
Dr. Nancy Bohannon, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $265,062
Endocrinology, Diabetes & Metabolism $265,062
Lewis Blevins, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $158,184
Endocrinology, Diabetes & Metabolism $158,184
Dr. Wade Aubry, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $104,039
Endocrinology, Diabetes & Metabolism $104,039
Dr. Jennifer Perkins, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $84,954
Endocrinology, Diabetes & Metabolism $84,954
Dr. Daniel Bikle, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $23,160
Endocrinology, Diabetes & Metabolism $23,160